Following the recall of the Raindrop corneal inlay, efforts must be made to notify all remaining affected patients
Harvey Carter | | Hot Topic
As some of you may know, the original maker of the Raindrop corneal inlay, Revision Optics (RVO), abruptly closed its doors on January 30, 2018. On October 22, 2018, the US Food and Drug Administration issued an FDA Safety Communication – a recall of the Raindrop corneal inlay (1). This FDA recall followed the FDA’s premarket approval of the Raindrop corneal inlay on June 29, 2016 (2).
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine